Edition:
United States

Aurinia Pharmaceuticals Inc (AUP.TO)

AUP.TO on Toronto Stock Exchange

7.65CAD
3:01pm EDT
Change (% chg)

$0.17 (+2.27%)
Prev Close
$7.48
Open
$7.41
Day's High
$7.75
Day's Low
$7.41
Volume
24,505
Avg. Vol
29,483
52-wk High
$9.10
52-wk Low
$5.68

Chart for

About

Aurinia Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company operating in the field of nephrology and autoimmunity. The Company's primary business is the development of a therapeutic drug to treat autoimmune diseases, in particular lupus nephritis (LN). It is focused on the development of its lead... (more)

Overall

Beta: 3.06
Market Cap(Mil.): $686.41
Shares Outstanding(Mil.): 85.32
Dividend: --
Yield (%): --

Financials

  AUP.TO Industry Sector
P/E (TTM): -- 119.85 32.14
EPS (TTM): -0.73 -- --
ROI: -25.96 1.96 12.83
ROE: -29.71 1.12 14.95

BRIEF-Aurinia Reports Qtrly Loss Per Share $0.18

* AURINIA REPORTS FIRST QUARTER FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

May 10 2018

Earnings vs. Estimates